Jaguar Health (JAGX) Common Equity (2014 - 2026)

Jaguar Health (JAGX) has 13 years of Common Equity data on file, last reported at -$15.8 million in Q1 2026.

• On a quarterly basis, Common Equity fell 1997.83% year-over-year to -$15.8 million in Q1 2026; TTM through Mar 2026 was -$15.8 million, a 1997.83% decrease from a year earlier, with the FY2025 full-year figure at -$18.7 million, down 387.77% from the prior year.
• Common Equity for Q1 2026 stood at -$15.8 million, up from -$18.7 million in the prior quarter.
• Over the last five years, Common Equity for JAGX reached as high as $16.6 million in Q2 2024 and fell as low as -$18.7 million in Q4 2025.
• Historically, Common Equity has averaged $3.4 million across 5 years, with a median of $4.9 million in 2023.
• Across the five-year window, Common Equity jumped 824.93% in 2024 and tumbled 1997.83% in 2026, its largest moves.
• Year by year, Common Equity stood at -$1.4 million in 2022, then jumped by 460.34% to $4.9 million in 2023, then soared by 32.61% to $6.5 million in 2024, then tumbled by 387.77% to -$18.7 million in 2025, then climbed by 15.71% to -$15.8 million in 2026.
• Per Business Quant data, the three most recent Common Equity figures were -$15.8 million in Q1 2026, -$18.7 million in Q4 2025, and $4.4 million in Q3 2025.